![Zorbtive [somatropin (rDNA origin) for injection]](images/Zorbtive_180.png)
How SeroCareSM
can help Zorbtive patients
Helpful information for people with SBS considering Zorbtive treatment
Clinical information about Zorbtive for health professionals
Clinical opinions about Zorbtive and goals of treatment for Short Bowel Syndrome
 |
| “I want to make the right decisions for me about SBS treatment.” |
You and your doctor may decide that Zorbtive® [somatropin (rDNA origin) for injection] treatment deserves careful consideration.
You and your doctor may then decide that Zorbtive, and its potential to reduce your dependence on parenteral nutrition, is right for you.
The Zorbtive Resource Center exists to help you and your doctor make a decision about treatment, and then to support you through the 28 days of treatment. (Note: Treatment for more than 28 days has not been adequately studied.)
Go here to find out about the Zorbtive patient-support team.
Before and during Zorbtive treatment, you and your doctor have our complete support.
Helpful Information for People with SBS
Considering Zorbtive Treatment
Here you will find “Understanding Zorbtive Treatment,” our patient handbook, plus the Zorbtive Full Prescribing Information, and the Zorbtive Patient Information Leaflet.
Zorbtive Clinical Information for Health Professionals
This section for health professionals includes a Treatment Guideline, a journal-article reprint where data from the Zorbtive pivotal trial were published, and a Clinical Review.
The glossary contains a short definition for some of the medical terms found on this web site.
These links may contain information you find helpful about Short Bowel Syndrome and available treatment.
How SeroCareSM can help
Zorbtive patients
Helpful information for people with SBS, considering
Zorbtive treatment
Clinical information about Zorbtive for health professionals
Clinical opinions about Zorbtive and goals
of treatment for Short Bowel Syndrome
Glossary
Links
Home
Zorbtive® [somatropin (rDNA origin) for injection] is indicated for the treatment of Short Bowel Syndrome (SBS) in patients receiving specialized nutritional support. Optimal management of SBS may include dietary adjustments, enteral feedings, parenteral nutrition, and fluid and micronutrient supplements, as needed.
Some common side effects of Zorbtive treatment include muscle and joint pain, and fluid retention (swelling).
Zorbtive may also cause serious side effects such as inflammation of the pancreas (pancreatitis), diabetes or
other blood sugar problems, pain, numbness or tingling in the wrist and hand, or increased blood pressure
in the brain. Make sure and talk with your doctor about these side effects.
Do not take Zorbtive if you have any of the following serious medical conditions: open-heart surgery; stomach-area (abdominal) surgery; an accident; breathing problems (respiratory failure); cancer; or, allergy to Zorbtive or other growth hormone medications.
This information is not intended to replace discussions with your healthcare professional.
For additional information about Zorbtive, please read the Zorbtive Patient Information Leaflet
and Zorbtive Full Prescribing Information and talk to your doctor. You can also call SeroCareSM
toll free at 800-714-2437. Zorbtive is available by prescription only.
This Web site was developed by EMD
Serono, Inc. (emdserono.com), makers of Zorbtive, to educate SBS
patients
and interested healthcare professionals about this treatment for Short Bowel
Syndrome. Zorbtive is exclusively marketed by
Emmaus Medical, Inc. (emmausmedical.com),
Tel: 1-877-420-6493.
This site contains medical information that is intended for residents of the United States
only and is not meant to substitute for the advice provided by a medical professional.
Always consult a doctor if you have health concerns. Use and access of this
site is subject to the terms and conditions as set out in our Legal Statement
and Privacy Policy.
© 2007 EMD Serono, Inc. All rights reserved. 